Ignite Creation Date:
2024-05-05 @ 9:35 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00005645
Status:
WITHDRAWN
Last Update Posted:
2018-09-18
First Post:
2000-05-02
Brief Title:
ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment
Sponsor:
Genzyme a Sanofi Company
Organization:
Sanofi
Key Dates - Follows AllAPIJSON File Order
Start Date:
1999-05
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2000-05-02
First Submit QC Date:
May 25 2004
Study First Post Date:
2004-05-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-09-16
Last Update Post Date:
2018-09-18
Last Update Post Date Type:
ACTUAL